Pharmaceutical News and Articles

Coffee Linked to Higher Cognitive Performance in Seniors With A-Fib

For elderly patients with atrial fibrillation, regular coffee consumption is associated with higher cognitive performance, according to a study published online

CagriSema Demonstrates Superior Weight Loss in Adults with Obesity or Overweight in the REDEFINE 1 Trial

Bagsv rd, Denmark, 20 December 2024 Novo Nordisk today announced headline results from REDEFINE 1, a phase 3 trial in the global REDEFINE programme. REDEFINE 1

Lexicon Announces Receipt of Complete Response Letter for Zynquista (sotagliflozin)

Atogepant Superior for Efficacy, Functional Measures in Migraine

For adults with migraine, atogepant 60 mg once daily was superior to placebo for efficacy and functional measures of treatment across three trials, according to

Neurological Outcomes Worsen With Gestational HTN, Preeclampsia, Eclampsia

Gestational hypertension, preeclampsia, and eclampsia are associated with an increased risk for neurological outcomes in the months or years after giving birth,

Study IDs Specific Anaphylactic Triggers Linked to Symptoms, Treatment

Specific anaphylactic triggers are associated with symptoms and treatments, according to a study published online Nov. 15 in the International Archives of Aller

Quick Fix? New Migraine Medicine May Start Working Right Away

Migraine patients often suffer a long time before docs zero in on the best dosage for drugs designed to prevent their terrible symptoms. But a recently approved

2020 to 2023 Saw Increase in Buprenorphine Dispensing for Teens

Buprenorphine dispensing increased among adolescents and decreased among young adults between 2020 and 2023, according to a research letter published online Dec

Therapeutic-Dose Anticoagulation Linked to Lower Mortality in COVID-19

For patients hospitalized for COVID-19, administration of therapeutic-dose versus prophylactic-dose anticoagulation with heparins is associated with lower 28-da

FDA Approves Generic GLP-1 Medicine For Diabetes Treatment

The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living